文献速递临床试验与 GCP

黄斑裂孔手术体位(PIMS):一项随机对照试验的统计分析计划

Positioning In Macular hole Surgery (PIMS): statistical analysis plan for a randomised controlled trial.
PubMed 文献 · Trials · 2017-06-13

PIMS试验为多中心、平行组、优效性随机对照试验,纳入192例特发性全层黄斑裂孔(≥400 μm)患者,术后随机分为面朝下体位组或面朝前体位组,每日至少8小时、持续5天。主要结局为术后3个月黄斑裂孔闭合成功率,以优势比(95%CI)报告,并校正裂孔大小和晶状体状态。

要点

  • PIMS试验评估大(≥400 μm)黄斑裂孔术后建议面朝下体位是否提高手术成功率。
  • 纳入192例,1:1随机至面朝下或面朝前体位,每日至少8小时、持续5天。
  • 主要结局为术后3个月黄斑裂孔闭合,效应以校正优势比及95%CI报告。

核心结论

  • PIMS试验将评估术后建议面朝下体位是否提高大(≥400 μm)黄斑裂孔的手术闭合成功率。

研究设计与样本

  • 多中心、平行组、优效性随机对照试验,1:1随机,计划纳入192例特发性全层黄斑裂孔(≥400 μm)患者。
  • 术后随机分为面朝下体位或面朝前体位,每日至少8小时(可连续或非连续),持续5天。
  • 纳入标准包括:OCT测得单眼或双眼特发性全层黄斑裂孔直径≥400 μm;选择行黄斑裂孔手术,伴或不伴同时行超声乳化及人工晶状体植入;有能力且愿意采取面朝下或非活动性面朝前体位;提示黄斑裂孔的视力下降病史≤12个月。
  • 主要结局为术后3个月黄斑裂孔成功闭合,效应以优势比及95%CI报告,校正基线裂孔大小和晶状体状态。

关键数值与推荐

  • 主要结局:术后3个月黄斑裂孔成功闭合。
  • 次要结局(3个月):因黄斑裂孔行或计划进一步手术(限于闭合失败者);患者报告体位体验;患者报告若在随访时已知情况是否仍会选择手术;采用Snellen视力表在6 m标准距离测得的最佳矫正视力(BCVA);采用国家眼科研究所视觉功能问卷(VFQ-25)评估的患者报告健康与生活质量。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The treatment of idiopathic full-thickness macular holes involves surgery to close the hole. Some surgeons advise patients to adopt a face-down position to increase the likelihood of successful macular hole closure. However, patients often find the face-down positioning arduous. There is a lack of conclusive evidence that face-down positioning improves the outcome. The 'Positioning In Macular hole Surgery' (PIMS) trial will assess whether advice to position face-down after surgery improves the surgical success rate for the closure of large (≥400 μm) macular holes. METHODS/DESIGN: The PIMS trial is a multicentre, parallel-group, superiority clinical trial with 1:1 randomisation. Patients (n = 192) with macular holes (≥400 μm) will be randomised after surgery to either face-down positioning or face-forward positioning for at least 8 h (which can be either consecutive or nonconsecutive) a day, for 5 days following surgery. Inclusion criteria are: presence of an idiopathic full-thickness macular hole ≥400 μm in diameter, as measured by optical coherence tomography (OCT) scans, on either or both eyes; patients electing to have surgery for a macular hole, with or without simultaneous phacoemulsification and intraocular lens implant; ability and willingness to position face-down or in an inactive face-forward position; a history of visual loss suggesting a macular hole of 12 months' or less duration. The primary outcome is successful macular hole closure at 3 months post surgery. The treatment effect will be reported as an odds ratio with 95% confidence interval, adjusted for size of macular hole and phakic lens status at baseline. Secondary outcome measures at 3 months are: further surgery for macular holes performed or planned (of those with unsuccessful closure); patient-reported experience of positioning; whether patients report they would still have elected to have the operation given what they know at follow-up; best-corrected visual acuity (BCVA) measured using Snellen charts at a standard distance of 6 m; patient-reported health and quality of life assessed using the National Eye Institute Visual Function Questionnaire (VFQ-25). DISCUSSION: The PIMS trial is the first multicentre randomised control trial to investigate the value of face-down positioning following macular hole standardised surgery. TRIAL REGISTRATION: International Standard Randomised Controlled Trials Number registry, ID: ISRCTN12410596. Registered on 11 February 2015. United Kingdom Clinical Research Network, ID: UKCRN17966 . Registered on 26 November 2014.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Bell L, Hooper R, Bunce C, et al. Positioning In Macular hole Surgery (PIMS): statistical analysis plan for a randomised controlled trial. Trials. 2017. PMID: 28610601. doi:10.1186/s13063-017-2020-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。